NCT02796807View on ClinicalTrials.gov

Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Prostate Cancer
Interventions
DRUG

68Ga-HBED-CC-PSMA (DKFZ-11) PET/CT

Trial Locations (1)

H3T1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

NCT02796807 - Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer | Biotech Hunter | Biotech Hunter